Issue · Criminal Justice

Criminal Justice (Drug Policy)

Every criminal justice bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
35
119th Congress
Top supporter
Adam B. Schiff
100% support rate
Top opponent
Amy Klobuchar
0% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving drug policy in United States

Legislators moving drug policy in United States
Legislator Party Stance Support rate Votes
Adam B. Schiff
Adam B. Schiff Senate
D
Strong +
100% 3
Chris Van Hollen
Chris Van Hollen Senate
D
Strong +
100% 3
Christopher Murphy
Christopher Murphy Senate
D
Strong +
100% 3
Cory A. Booker
Cory A. Booker Senate
D
Strong +
100% 3
Edward J. Markey
Edward J. Markey Senate
D
Strong +
100% 3
Amy Klobuchar
Amy Klobuchar Senate
D
Strong −
0% 3
Andrea Salinas
Andrea Salinas House · District 6
D
Strong −
0% 3
Andy Kim
Andy Kim Senate
D
Strong −
0% 3
Angus S. King, Jr.
Angus S. King, Jr. Senate
I
Strong −
0% 3
April McClain Delaney
April McClain Delaney House · District 6
D
Strong −
0% 3
Showing 1–10 of 35 bills

All criminal justice bills

in committee · United States · Senate Aug 8, 2026

S 5383: End Gas Station Heroin Act

The End Gas Station Heroin Act adds two specific kratom compounds, 7-hydroxymitragynine and mitragynine pseudoindoxyl, to the federal list of Schedule I controlled substances. However, it includes an exemption for these compounds when they occur naturally in finished kratom products that meet strict concentration limits, while explicitly excluding synthetically produced or chemically concentrated versions from this protection. The bill also creates a new enforcement mechanism that treats any emerging synthetic opioid with greater potency than morphine as a Schedule I controlled substance if it is manufactured or distributed for commercial sale. This provision targets the production and distribution of these substances but explicitly prohibits criminal or civil penalties for simple possession or personal use by consumers.
in committee · United States · Senate Aug 6, 2026

S 5320: Insider Trading Prohibition Act

The Insider Trading Prohibition Act creates a new federal criminal statute that makes it illegal to buy or sell securities while knowingly in possession of material, nonpublic information that was obtained wrongfully. The bill defines wrongful conduct to include actions such as theft, breach of fiduciary duty, or unauthorized access to data, and explicitly covers situations where an individual consciously avoids knowing the details of how the information was acquired. It also prohibits sharing this type of sensitive information if the sender knows it will be used for trading. While the law allows for certain exemptions, including transactions made under pre-existing Rule 10b5-1 plans, it ensures that these new penalties apply in addition to existing legal remedies.
Sub-Topics Drug Policy
in committee · United States · House Jul 23, 2026

HR 9904: Deputy Darren Almendarez Act

This bill, known as the Deputy Darren Almendarez Act, adds a new federal crime for knowingly possessing or purchasing catalytic converters removed from vehicles with the intent to sell or distribute them. It directly affects individuals involved in the removal and resale of these parts, as well as businesses like scrap yards and repair shops, by establishing penalties of up to five years in prison and fines of $100,000 for first offenses. The law includes specific exceptions that allow for legal possession or purchase if the converter was removed by a vehicle owner, acquired during official duties by authorized entities, or bought from licensed businesses that follow state and local identification rules. For repeat offenders, the potential prison sentence increases to ten years and the fine limit rises to $200,000.
in committee · United States · House Jul 23, 2026

HR 9937: No Leniency for Fentanyl Dealers Act

This bill, known as the No Leniency for Fentanyl Dealers Act, aims to increase penalties for trafficking fentanyl and other synthetic opioids while enhancing detection efforts by the U.S. Postal Service. It lowers the quantity thresholds required for federal felony charges and mandates that sentencing guidelines be updated to reflect these stricter penalties. Additionally, the legislation directs the Postmaster General to purchase more chemical screening devices and hire scientists to identify illegal drugs in mail shipments, authorizing $9 million in funding to support these interdiction activities.
Sub-Topics Drug Policy Sentencing
in committee · United States · House Feb 4, 2025

HR 923: Stop Arming Cartels Act of 2025

The Stop Arming Cartels Act of 2025 prohibits civilian possession, sale, or transfer of rifles capable of firing .50 caliber ammunition, with exceptions for government use and rifles lawfully owned before the bill's enactment. It requires owners of such rifles to register them with the federal government within 12 months, without fees, and adds these rifles to the National Firearms Act registry. The bill also creates new federal firearm restrictions for significant foreign narcotics traffickers identified under the Foreign Narcotics Kingpin Designation Act and expands reporting requirements for rifle sales to include all rifles. This directly affects civilian rifle owners, sellers, and individuals designated as foreign narcotics traffickers.
in committee · United States · Senate Jun 3, 2026

S 4671: Federal Firearms Licensee Protection Act of 2026

The Federal Firearms Licensee Protection Act of 2026 increases penalties for individuals who knowingly violate federal laws regarding the possession of firearms by licensed dealers. Specifically, it raises the maximum prison sentence for such violations to 20 years and mandates a minimum of three years in prison if the offense occurs during a burglary of a licensed business. The law also sets a five-year minimum sentence if the violation happens during a robbery. These changes directly affect federal firearms licensees and anyone attempting to illegally possess firearms from them.
in committee · United States · Senate May 18, 2026

S 4553: Aaron Salter, Jr., Responsible Body Armor Possession Act

This bill, known as the Aaron Salter, Jr., Responsible Body Armor Possession Act, prohibits civilians from buying, owning, or possessing enhanced body armor. The law defines enhanced body armor as protective gear that meets or exceeds the ballistic resistance of RF1 armor, which includes certain helmets and shields. Exceptions are made for law enforcement officers, government agencies, and individuals who already legally owned such armor before the law takes effect. Violating this ban could result in a fine, up to five years in prison, or both penalties.
in committee · United States · House May 12, 2026

HR 8766: Deal Death, Face Death Act

This bill, known as the Deal Death, Face Death Act, modifies federal drug laws to impose the death penalty on individuals convicted of distributing fentanyl or fentanyl-related substances if the use of those drugs results in a death. Currently, the Controlled Substances Act allows for life imprisonment in cases where drug use causes death or serious injury, but this legislation specifically targets fentanyl by mandating capital punishment for such outcomes. The law also increases maximum fines for these offenses, raising the limit for individuals to $2 million and for organizations to $10 million. Directly affecting drug traffickers and distributors, the bill aims to strengthen penalties for the distribution of synthetic opioids by adding a specific provision that triggers the ultimate punishment when fatalities occur.
Sub-Topics Drug Policy
in committee · United States · House Mar 19, 2026

HR 8000: END 7-OH Act

This bill proposes to add 7-hydroxymitragynine to Schedule I of the Controlled Substances Act, classifying it as a controlled substance. The legislation specifically excludes naturally occurring 7-hydroxymitragynine found in kratom plants from this classification while including synthetic versions. This change would require federal regulation of synthetic forms of the compound but would not affect kratom products containing the substance in its natural state. The bill directly impacts pharmaceutical manufacturers and synthetic drug producers who would need to comply with new federal scheduling requirements.
Sub-Topics Drug Policy
in committee · United States · House Jul 21, 2026

HR 7970: STOP Nitazenes Act

This bill, known as the STOP Nitazenes Act, directs the federal government to permanently classify nitazenes and related synthetic opioids as Schedule I controlled substances, placing them in the same legal category as heroin and fentanyl. The legislation specifically targets a broad range of chemical compounds, including etonitazene and other variants, by defining them as 2-benzylbenzimidazole opioids and requiring the Attorney General to publish a list of qualifying substances. Under the bill, any nitazene substance temporarily scheduled under emergency provisions would be made permanently scheduled upon enactment, ensuring long-term federal control. The law also mandates that the Attorney General issue implementing rules within one year, allowing for immediate interim enforcement while providing opportunities for public comment before final regulations are established.
Showing 1 to 10 of 35 bills
1 2 3 4 Next